Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused...
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial execution as adoption of Canopus by eXeX accelerates across hospital systems in the United States and United...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: ...
Company to Host Conference Call on Wednesday, August 5, 2026, at 8:30 am Eastern Time
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
NEW YORK , May 26, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Orthofix Medical Inc. (NASDAQ: OFIX) on behalf of the company's shareholders. The investigation...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: ...
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced new pediatric limb reconstruction innovations that expand treatment options for pediatric and small...